These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17023870)

  • 1. Pharmacogenetics of methylphenidate response in preschoolers with ADHD.
    McGOUGH J; McCRACKEN J; Swanson J; Riddle M; Kollins S; Greenhill L; Abikoff H; Davies M; Chuang S; Wigal T; Wigal S; Posner K; Skrobala A; Kastelic E; Ghuman J; Cunningham C; Shigawa S; Moyzis R; Vitiello B
    J Am Acad Child Adolesc Psychiatry; 2006 Nov; 45(11):1314-1322. PubMed ID: 17023870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder.
    McGough JJ; McCracken JT; Loo SK; Manganiello M; Leung MC; Tietjens JR; Trinh T; Baweja S; Suddath R; Smalley SL; Hellemann G; Sugar CA
    J Am Acad Child Adolesc Psychiatry; 2009 Dec; 48(12):1155-64. PubMed ID: 19858760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder.
    Froehlich TE; Epstein JN; Nick TG; Melguizo Castro MS; Stein MA; Brinkman WB; Graham AJ; Langberg JM; Kahn RS
    J Am Acad Child Adolesc Psychiatry; 2011 Nov; 50(11):1129-1139.e2. PubMed ID: 22024001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.
    Stein MA; Sarampote CS; Waldman ID; Robb AS; Conlon C; Pearl PL; Black DO; Seymour KE; Newcorn JH
    Pediatrics; 2003 Nov; 112(5):e404. PubMed ID: 14595084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder.
    Gruber R; Joober R; Grizenko N; Leventhal BL; Cook EH; Stein MA
    J Child Adolesc Psychopharmacol; 2009 Jun; 19(3):233-9. PubMed ID: 19519258
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Naumova D; Grizenko N; Sengupta SM; Joober R
    World J Biol Psychiatry; 2019 Jul; 20(6):486-495. PubMed ID: 29182037
    [No Abstract]   [Full Text] [Related]  

  • 7. Catechol-O-methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children.
    Kereszturi E; Tarnok Z; Bognar E; Lakatos K; Farkas L; Gadoros J; Sasvari-Szekely M; Nemoda Z
    Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1431-5. PubMed ID: 18214865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics.
    Froehlich TE; McGough JJ; Stein MA
    CNS Drugs; 2010 Feb; 24(2):99-117. PubMed ID: 20088618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.
    Pelham WE; Aronoff HR; Midlam JK; Shapiro CJ; Gnagy EM; Chronis AM; Onyango AN; Forehand G; Nguyen A; Waxmonsky J
    Pediatrics; 1999 Apr; 103(4):e43. PubMed ID: 10103335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD.
    Greenhill L; Kollins S; Abikoff H; McCracken J; Riddle M; Swanson J; McGough J; Wigal S; Wigal T; Vitiello B; Skrobala A; Posner K; Ghuman J; Cunningham C; Davies M; Chuang S; Cooper T
    J Am Acad Child Adolesc Psychiatry; 2006 Nov; 45(11):1284-1293. PubMed ID: 17023867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a novel biphasic controlled-release methylphenidate formula in adults with attention-deficit/hyperactivity disorder: results of a double-blind, placebo-controlled crossover study.
    Jain U; Hechtman L; Weiss M; Ahmed TS; Reiz JL; Donnelly GA; Harsanyi Z; Darke AC
    J Clin Psychiatry; 2007 Feb; 68(2):268-77. PubMed ID: 17335326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1).
    Kooij JS; Boonstra AM; Vermeulen SH; Heister AG; Burger H; Buitelaar JK; Franke B
    Am J Med Genet B Neuropsychiatr Genet; 2008 Mar; 147B(2):201-8. PubMed ID: 17955457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term side effects of stimulant medication are increased in preschool children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study.
    Firestone P; Musten LM; Pisterman S; Mercer J; Bennett S
    J Child Adolesc Psychopharmacol; 1998; 8(1):13-25. PubMed ID: 9639076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder.
    Handen BL; Johnson CR; Lubetsky M
    J Autism Dev Disord; 2000 Jun; 30(3):245-55. PubMed ID: 11055460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A candidate gene investigation of methylphenidate response in adult attention-deficit/hyperactivity disorder patients: results from a naturalistic study.
    Hegvik TA; Jacobsen KK; Fredriksen M; Zayats T; Haavik J
    J Neural Transm (Vienna); 2016 Aug; 123(8):859-65. PubMed ID: 27091191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylphenidate for children and adolescents with autism spectrum disorder.
    Sturman N; Deckx L; van Driel ML
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011144. PubMed ID: 29159857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Epstein T; Patsopoulos NA; Weiser M
    Cochrane Database Syst Rev; 2014 Sep; (9):CD005041. PubMed ID: 25230710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
    Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA
    Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of methylphenidate in childhood attention-deficit/hyperactivity disorder: long-term effects.
    Gomez-Sanchez CI; Carballo JJ; Riveiro-Alvarez R; Soto-Insuga V; Rodrigo M; Mahillo-Fernandez I; Abad-Santos F; Dal-Ré R; Ayuso C
    Sci Rep; 2017 Sep; 7(1):10391. PubMed ID: 28871191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine receptor 4 (DRD4) 7-repeat allele predicts methylphenidate dose response in children with attention deficit hyperactivity disorder: a pharmacogenetic study.
    Hamarman S; Fossella J; Ulger C; Brimacombe M; Dermody J
    J Child Adolesc Psychopharmacol; 2004; 14(4):564-74. PubMed ID: 15662148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.